NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative ...

Marine Atlantic says that changing its rates to lower user costs amid a tumultuous on-again-off-again trade war between ...

NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage company specializing in “off-the-shelf” allogeneic cell therapy products for ...

Z URICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their ...

NLS Pharmaceutics (NLSP) announces new preclinical findings on AEX-2, reinforcing its potential as a first-in-class non-sulfonamide dual orexin ...

Revolutionizing Diabetes Treatment: Introduction of cutting-edge, multi-targeted innovation to transform diabetes care. Diabetes more than just a Metabolic Disorder: Diabetes is a multi-systemic ...

MARSHALL — The Minnewaska girls basketball team relied on its offensive rebounding and gritty, aggressive defense to knock ...

Kadimastem and iTolerance believe that the completion of the pre-IND meeting is a significant milestone toward the clinical ...

Indore: India must harness the transformative potential of laser technology to drive innovation and self-reliance in ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.